Rapport Therapeutics, Inc. Common Stock ( RAPP) - Stock Earnings
RAPP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -33.8 million USD | — USD |
| 2026Q1 | -19.9 million USD | 20.0 million USD |
| 2026Q2 | -56.6 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
RAPP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -34.8 million USD | — USD |
| 2024 | -78.3 million USD | — USD |
| 2025 | -111.5 million USD | — USD |
| 2026 Est. | — | — |
RAPP
Price: $48.26
52 week price:
Earnings Per Share: -2.96 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.3 billion